Data for: Post-Marketing Safety Analysis of Upadacitinib in Atopic Dermatitis: An FDA Adverse Reporting System (FAERS) Review of Boxed Warning Related Adverse Events

Name: Data for: Post-Marketing Safety Analysis of Upadacitinib in Atopic Dermatitis: An FDA Adverse Reporting System (FAERS) Review of Boxed Warning Related Adverse Events
Creator: Aditya Joshi
Published: 2025-04-21T22:58:17.482Z
Keywords: Dermatology, Pharmacovigilance

Joshi, Aditya

doi:10.17632/zhpjxpnfp2.1

Data for: Post-Marketing Safety Analysis of Upadacitinib in Atopic Dermatitis: An FDA Adverse Reporting System (FAERS) Review of Boxed Warning Related Adverse Events

Published: 21 April 2025| Version 1 | DOI: 10.17632/zhpjxpnfp2.1

Contributor:

Aditya Joshi

Description

Supplemental Data Tables for "Post-Marketing Safety Analysis of Upadacitinib in Atopic Dermatitis: An FDA Adverse Reporting System (FAERS) Review of Boxed Warning Related Adverse Events"

Files

Institutions

University of Washington

Data for: Post-Marketing Safety Analysis of Upadacitinib in Atopic Dermatitis: An FDA Adverse Reporting System (FAERS) Review of Boxed Warning Related Adverse Events

Description

Files

Institutions

Categories

Licence